MAL23086005XPrescription (MAL-A)

Gaviscon Infant Powder for Oral Suspension

Generic Molecule: Sodium Alginate

ACTIVE & APPROVEDValid till: 3 Aug 2028
NPRA Official Regulatory Summary

Gaviscon Infant Powder for Oral Suspension is a KKM-approved Prescription Medicine registered under MAL number MAL23086005X by RB (HEALTH) MALAYSIA SDN BHD. Its active ingredient is sodium alginate 225 mg 650 mg, Magnesium alginate 87.5 mg 650 mg, manufactured by RECKITT BENCKISER HEALTHCARE (UK) LIMITED.

Holder (PRH)
RB (HEALTH) MALAYSIA SDN BHD
Manufacturer
RECKITT BENCKISER HEALTHCARE (UK) LIMITED
First Registered
3 Aug 2023
Validity
3 Aug 2028

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

2 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
sodium alginate225 mg 650 mgFind Brands
Magnesium alginate87.5 mg 650 mgFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL23086005X exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is Gaviscon Infant Powder for Oral Suspension approved by KKM / NPRA?

Yes. Gaviscon Infant Powder for Oral Suspension is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL23086005X with current status PRODUCT APPROVED. Registration was filed by RB (HEALTH) MALAYSIA SDN BHD.

What are the active ingredients of Gaviscon Infant Powder for Oral Suspension?

The declared active therapeutic components are: sodium alginate 225 mg 650 mg, Magnesium alginate 87.5 mg 650 mg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 20 registered brand formulations containing identical active ingredients (Sodium Alginate). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: Gaviscon Infant Powder for Oral Suspension (MAL23086005X) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.